The true cost of pharmacological disease prevention
BMJ
.
2011 Apr 19;342:d2175.
doi: 10.1136/bmj.d2175.
Authors
Teppo L N Järvinen
1
,
Harri Sievänen
,
Pekka Kannus
,
Jarkko Jokihaara
,
Karim M Khan
Affiliation
1
Department of Orthopaedic Surgery, University of Tampere, 33014 Tampere, Finland. teppo.jarvinen@uta.fi
PMID:
21505222
DOI:
10.1136/bmj.d2175
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Cost-Benefit Analysis
Drug Costs*
Humans
Pharmaceutical Preparations / economics*
Preventive Medicine / economics*
Substances
Pharmaceutical Preparations